Regencell Bioscience Lim... (RGC)

AI Score

Unlock

25.66

-9.21 (-26.41%)

At close: Mar 28, 2025, 3:59 PM

25.05

-2.38%

After-hours: Mar 28, 2025, 06:48 PM EDT

Regencell Bioscience Balance Sheet Statement

Table Mode

Year	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY13	FY12	FY11	FY10	FY09	FY07	FY06	FY05	FY04	FY02
Cash & Equivalents	2.96M	1.56M	6.42M	59.41K	386.98K	243.31K	228.8M	246.5M	219.6M	147.1M	280.9M	109.5M	205.3M	328.1M	170M	435M	162M	243M	288M	276M
Short-Term Investments	5M	10M	10M	n/a	n/a	n/a	n/a	n/a	n/a	3.8M	7M	n/a	6M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	97.68K	108.5K	114.3K	191.42K	18.72K	n/a	422.5M	379.4M	373.8M	341.5M	319.3M	192.9M	173.4M	121.5M	-885M	-806M	-671M	-383M	-225M	-121M
Receivables	152.78K	n/a	n/a	n/a	n/a	n/a	184M	155.1M	153.1M	n/a	129.4M	104.3M	n/a	69M	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	-56.55K	-27.6K	-7.44K	n/a	n/a	22.9M	20.9M	22.4M	17.8M	19M	17.8M	14.7M	12.3M	8M	8M	8M	7M	6M	6M
Other Current Assets	n/a	113.1K	27.6K	7.44K	n/a	n/a	27.6M	24.4M	43.1M	172.7M	28.8M	26.2M	120.5M	19.5M	95M	82M	71M	71M	82M	107M
Total Current Assets	8.11M	11.62M	16.44M	66.85K	386.98K	243.31K	463.3M	446.9M	438.2M	341.4M	465.1M	257.8M	346.5M	428.9M	273M	525M	241M	321M	376M	389M
Property-Plant & Equipment	226.51K	891.91K	1.46M	81.86K	108.32K	n/a	1.51B	1.39B	1.4B	1.46B	1.51B	1.46B	1.69B	1.82B	3.02B	2.73B	2.68B	2.39B	2.12B	1.81B
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	389.4M	373M	378.9M	374.3M	378.1M	295.6M	201M	190.5M	193M	181M	214M	213M	197M	227M
Total Long-Term Assets	324.2K	1M	1.57M	273.29K	127.04K	n/a	2.38B	2.2B	2.19B	2.2B	2.24B	1.95B	2.15B	2.21B	2.33B	2.11B	2.23B	2.22B	2.1B	1.92B
Total Assets	8.44M	12.62M	18.02M	340.13K	514.02K	243.31K	2.84B	2.65B	2.63B	2.54B	2.7B	2.21B	2.49B	2.64B	2.6B	2.63B	2.47B	2.54B	2.47B	2.31B
Account Payables	n/a	n/a	n/a	n/a	n/a	n/a	232.2M	194.8M	229.7M	165.7M	170.2M	157M	162.4M	198.5M	162M	183M	168M	182M	194M	154M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	186.2M	192.7M	203.4M	188.2M	181.8M	102.2M	98.5M	93.9M	14M	64M	21M	5M	5M	4M
Short-Term Debt	59.81K	438.26K	410.99K	3.68M	3.07M	2.08M	26.6M	25.5M	27.4M	26.6M	29.8M	22M	95.8M	17.1M	77M	n/a	52M	56M	47M	n/a
Other Current Liabilities	133.77K	168.65K	166.78K	655.8K	95K	n/a	116.4M	97M	90.8M	82.9M	111M	92.7M	112.3M	87M	113M	280M	263M	345M	119M	146M
Total Current Liabilities	193.58K	606.91K	577.76K	4.34M	3.16M	2.08M	561.4M	510M	551.3M	477M	506.4M	387.5M	469M	396.5M	366M	527M	556M	644M	412M	304M
Long-Term Debt	25.93K	25.41K	360.27K	n/a	n/a	n/a	2.34B	2.2B	2.23B	2.24B	2.19B	1.91B	1.9B	1.89B	77M	54M	61M	55M	71M	109M
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	393.3M	365.2M	315.1M	208.2M	207.9M	198.3M	195.7M	254.3M	144M	127M	91M	81M	64M	49M
Total Long-Term Liabilities	25.93K	25.41K	360.27K	n/a	n/a	n/a	3.14B	2.97B	2.96B	2.88B	2.82B	2.46B	2.45B	2.49B	560M	460M	152M	136M	135M	158M
Total Liabilities	219.51K	632.32K	938.03K	4.34M	3.16M	2.08M	3.7B	3.48B	3.51B	3.43B	3.42B	2.91B	2.98B	2.88B	2.84B	2.75B	2.49B	2.47B	1.67B	1.04B
Total Debt	85.74K	463.67K	771.25K	3.68M	3.07M	2.08M	2.37B	2.22B	2.26B	2.27B	2.22B	1.93B	1.99B	1.91B	154M	1.86B	1.88B	1.89B	1.08B	561M
Common Stock	130.00	130.00	130.00	100.00	100.00	100.00	100K	100K	100K	100K	100K	100K	100K	100K	n/a	n/a	n/a	n/a	n/a	n/a
Retained Earnings	-21.62M	-17.32M	-11.44M	-4M	-2.65M	-1.84M	70.9M	96.5M	64.2M	48.4M	71.8M	1.4M	9.4M	47M	24M	42M	30M	23M	64M	74M
Comprehensive Income	-45.77K	-86.66K	0.00	n/a	n/a	n/a	-2.24B	-2.15B	-2B	-1.5M	-2.4M	-4.3M	-12.2M	-1.25B	-9M	-1M	13M	-5M	n/a	n/a
Shareholders Equity	8.22M	12.03M	17.07M	-4M	-2.65M	-1.84M	-855.9M	-839.1M	-877.8M	-894.8M	-713.4M	-696.8M	-490.3M	-246.1M	-241M	-119M	-22M	69M	794M	1.27B
Total Investments	5M	10M	10M	n/a	n/a	n/a	n/a	n/a	n/a	3.8M	7M	n/a	6M	n/a	n/a	n/a	n/a	n/a	n/a	n/a